Human papillomaviruses (HPVs) have evolved over millions of years to propagate
themselves in a range of different animal species including humans. Viruses that have co …

Human Papillomavirus (HPV) research has been dominated by the study of a subset of
Alpha papillomaviruses that together cause almost 5% of human cancers worldwide, with …

Human papillomaviruses (HPVs) are ubiquitous, well adapted to their host and cleverly
sequestered away from immune responses. HPV infections can be productive, subclinical or …

This guideline is an update of the 2011 European Guideline for the Management of
Anogenital Warts. It is intended to support best practice in the care of patients with …

Background Quadrivalent human papillomavirus (HPV) vaccine has high efficacy in clinical
trials but no reports describe its effects at a population level. From July, 2007, Australia was …

Background Although new HPV vaccines have been developed and are in the process of
implementation, anogenital warts remain a very frequent problem in clinical practice …

The most common cause of mortality related to human papillomavirus (HPV) infection is
cervical cancer. However, male HPV infection is also an important concern, both for the …

Background The role of human papillomavirus (HPV) in malignant and non-malignant
genital diseases in women is well known and the corresponding epidemiological burden …

An estimated 499 million curable sexually transmitted infections (STIs; gonorrhea,
chlamydia, syphilis, and trichomoniasis) occurred globally in 2008. In addition, well over 500 …

Objective To assess the cost effectiveness of routine vaccination of 12 year old schoolgirls
against human papillomavirus infection in the United Kingdom. Design Economic …